Literature DB >> 9344640

Microcirculatory disturbances of the pancreas in cerulein-induced acute pancreatitis in rats with reference to L-arginine, heparin, and procaine treatment.

M Dobosz1, S Hac, L Mionskowska, S Dobrowolski, Z Wajda.   

Abstract

Local microcirculatory dysfunction within the pancreatic gland might be an important factor in the conversion of oedematous to necrotizing pancreatitis. Therapeutic agents, improving the pancreatic blood flow, might be valuable in acute pancreatitis treatment. An influence of nitric oxide, heparin and procaine treatment on microcirculatory values in acute pancreatitis (AP) in rats was investigated. Acute pancreatitis was induced by i.p. injection of cerulein in four doses of 15 microg kg-1 each at 1-h intervals. The rats with pancreatitis were divided into five groups, 12 animals each. One group remained without treatment, four groups were treated i.p. either with NO synthase inhibitor L-NNA (2x25 mg kg-1 or heparin 2x2.5 mg kg-1 or L-arginine 2x100 mg kg-1 or procaine 2x25 mg kg-1. Five control groups, ten animals each, received saline, L-NNA, heparin, L-arginine or procaine only. Five hours after the first ceruleine injection microcirculatory values within the pancreas were measured by means of laser Doppler flowmetry. Acute pancreatitis caused a significant drop of microcirculatory value to 37% of the basal value. The L-NNA administration resulted in a further insignificant reduction of the pancreatic blood flow to 34%. An improvement of microcirculation was observed in rats with pancreatitis receiving heparin (76%) and L-arginine (72%). Procaine had no effect on microcirculatory disturbances within the pancreas in rats with pancreatitis. Cn-induced acute pancreatitis (AP) causes microcirculatory deterioration within the pancreas. Heparin and nitric oxide donor, L-arginine, might be considered as therapeutic agents, improving the diminished pancreatic tissue perfusion observed in acute pancreatitis. Procaine does not improve the pancreatic blood flow in acute pancreatitis. Copyright 1997 The Italian Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9344640     DOI: 10.1006/phrs.1997.0200

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  6 in total

1.  Nitric oxide protects the ultrastructure of pancreatic acinar cells in the course of caerulein-induced acute pancreatitis.

Authors:  A Andrzejewska; G Jurkowska
Journal:  Int J Exp Pathol       Date:  1999-12       Impact factor: 1.925

Review 2.  Resveratrol: a medical drug for acute pancreatitis.

Authors:  Zhen-Hua Ma; Qing-Yong Ma
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

3.  Neutrophil engagement and septic challenge in acute experimental pancreatitis in rats.

Authors:  Stanisław Hać; Marek Dobosz; Jan-J Kaczor; Robert Rzepko; Ewa Aleksandrowicz-Wrona; Zdzisław Wajda; Zbigniew Sledziński; Jacek Krajewski
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

Review 4.  Influencing factors of pancreatic microcirculatory impairment in acute panceatitis.

Authors:  Zong-Guang Zhou; You-Dai Chen
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

5.  Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial.

Authors:  O Barkay; E Niv; E Santo; R Bruck; A Hallak; F M Konikoff
Journal:  Surg Endosc       Date:  2008-01-24       Impact factor: 4.584

6.  Epidural anaesthesia restores pancreatic microcirculation and decreases the severity of acute pancreatitis.

Authors:  Alp Demirag; Catherine M Pastor; Philippe Morel; Copin Jean-Christophe; Andreas W Sielenkämper; Nilgun Güvener; Gang Mai; Thierry Berney; Jean-Louis Frossard; Leo H Bühler
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.